funfun

Synovus: A Beat-Up Bank to Bet On

On Nov 22 08:00 PM See through it wrote:

> Lots of RECENT insider buys at prices above current levels. There's
> only one reason insiders buy...

But keep in mind, there were substantial insider purchases in Colonial Bancorp, another huge southeastern bank, shortly before it cratered into oblivion! ...funfun..

E. I. du Pont de Nemours and Company Q3 2009 Earnings Call Transcript

Fellow Investors,

Notwithstanding the personal attacks by rabid fans of DuPont and its historically sub-performing Management, all data cited in my opinions here can be verified and confirmed. There is no attempt to "mislead" readers on my part as has been dishonestly charged in retaliatory messages by DuPont Management cheerleaders.

...funfun..

E. I. du Pont de Nemours and Company Q3 2009 Earnings Call Transcript

Speaking of the looming expirations of the patents of DuPont's sole remaining two drugs, Cozaar® and Hyzaar®, DuPont Senior Management admitted on Nov 3 that DuPont's pre-tax Pharma earnings are expected to drop dramatically from $1.1 billion this year 2009 to only $300 to $350 million in 2010, and then down to $70 million in 2012. The fading Pharma "platform" is currently supplying about a third of DuPont's total PTOI, year-to-date, 2009.

The BIG BLACK HOLE of permanently disappearing DuPont Pharma profits has begun to erode the bottom-line by $750 to $800 million next year, it would seem.

REFERENCE: "Update3--DuPont Sees...," Reuters, 4:00 pm EST, Nov. 3, 2009.

...funfun..

10 Dividend Stocks for Enterprising Investors

Unlike Pfizer, which remains the number one global drug company, mismanaged DuPont has slid from number one to eight in revenues amongst chemical enterprises in ten years! This relentless decline, for which recent quarters show no signs of abatement, will continue to put pressure on the Company's rich yearly dividend of $1.64 a share, in my opinion. Lost sales, lost customers, lost talent and ideas do not create cash flow with vigour.

Merely the observation of one retail investor...funfun..

The World's Top Chemical Companies

The much shrunken DuPont Company as it continues to decline is beginning to look more and more like the General Motors of chemicals!

Both of these one-time mammoth industry leaders (GM was the largest motor company in the world; DuPont, the largest chemical company for most of the past century) suffered for decades from misfiring and mismanaging marginal leaders.

...funfun..

The World's Top Chemical Companies

Wow! DuPont which formerly was the largest, and unquestioned leader in the chemical industry has plunged from number one to number eight in the course of a single decade. This dramatic shrinkage was driven by a misfiring and stunningly mediocre Management!

In sharp contrast, BASF and Dow, first and second largest respectively, continue to grow robustly while DuPont continues to shrivel and retreat. DuPont's expected sales for the full year 2009 are projected at an anemic $26 billion. ...funfun..

Five Companies Worth Researching This Weekend

Additionally on DuPont's bleak prospects, DuPont Senior Management, specifically DuPont Executive Vice President Mark Vergnano, admitted to private investors less than a month ago, Oct. 6, 2009, that DuPont would not match its noticeably weak earnings of 2008, or diluted earnings per share of $2.20, until the earliest well into the next decade, 2012! This tells me the intervening years will show sick results.

...funfun..

Five Companies Worth Researching This Weekend

Pressure on DuPont's rich annual dividend of $1.64 per share will be intensifying as DuPont faces a looming BIG BLACK HOLE of vanishing Pharma earnings! The sure and certain expiration of the patents protecting DuPont Cozaar® and Hyzaar® will begin to blowtorch more than $1 billion of Pharma PTOI yearly. These two drugs are the only key assets remaining in DuPont's fading and phased-out Pharma "growth platform".

For perspective, in the first nine months of this year, 2009, Pharma accounted for circa one-third of total DuPont PTOI! DuPont's customarily secretive Management to date has said very little publicly about this BIG BLACK HOLE, but has indicated they will be more forthcoming this week on Nov. 3, 2009 at a conference for investors and analysts at the Company's World Headquarters For Sustainable Excellence in Wilmington, Delaware. Heads-up, fellow investors!

funfundvierzig...funfun..

E. I. du Pont de Nemours and Company Q3 2009 Earnings Call Transcript

Ms. Kullman in her introductory remarks brags about launching 323 "new products" for the quarter, making a total of 1107 "new products" year-to-date, "almost 50% more" over the year 2008 before she became CEO. Her implication, of course, is DuPont under her "leadership" is riding a wave of innovation.

However empirical observations and opinions from former and active DuPont employees on other internet blogsites, including the Yahoo! Finance DD board, suggest many of these touted "new products" may indeed and in fact be pre-existing DuPont products changed superficially or slightly by material composition or formula, or cosmetically by colour, packaging, size or labelling, undsoweiter.

Where are the revenues from all these "new products"?? In the spirit of transparency which she trumpets, Ms. Kullman should make a complete list of these "new products" available to the media, analysts, and investors. ...funfun..

E. I. du Pont de Nemours and Company Q3 2009 Earnings Call Transcript

Talk about slapping lipstick on the proverbial pig!

DuPont Executive Vice President, Jeffrey Keefer brags disingenuously, if not deceptively,

"DuPont had a strong third quarter..."

What in the world is he blabbering about?

Revenues cratered, down 20%!
World-wide volumes were down 12%!
Earnings per share were flat, if the nickel in tax benefits is factored out.

And Keefer goes on with his snake oil pitch,

"After accounting for the tax benefit, stilll a very, very, solid quarter"

Fellow investors, that is VERY, VERY misleading and distorting to frame one of the sickest, weakest DuPont quarters in memory in such a dishonest fashion! ...funfun..

Dow/Monsanto's New Corn: Latest Data

SmartStax will leave DuPont's struggling seed house, Pioneer Hi-Bred Int'l further behind on the highway of innovation. DuPont's first major effort at developing and commercialising a genetically modified seed trail, parodically called OptimumGAP, cannot be used on a stand-alone basis "without risk"!

...funfun..

Bank of America's Lewis Goes Packing

Lewis's legacy?

Leaves behind a fraud-infested bank stained with serial scandals, and millions of alienated bank and brokerage customers, tens of thousands of sacked employees, and BAC shareholders whose investments have been dramatically debased.

Lewis also leaves with a massive personal fortune paid to him in return for undeniably shabby "leadership" performance!

...funfun..

Why Did Du Pont's Charles Holliday Join BofA's Board?

The "leaders" of BAC just don't get it. Milliions of Americans and investors are unarguably repulsed by the spectacle of massive bonuses paid to inept corporate and bank CEOs in return for mediocre performance or worse. DuPont Chairman Chad Holliday is a master of grabbing outsized bonuses for himself and his circa 100 bobble-heading DuPont Vice Presidents in return for sub-performances and destroying shareholder value. Is that the kind of "expertise" for which the bank is looking, given BAC is embroiled in a sordid scandal over executive bonuses? ...funfun..

Why Did Du Pont's Charles Holliday Join BofA's Board?

To think that DuPont's bumbling über boss, Chad Holliday can bring "credibility" to this fraud-infested bank with its serial scandals is laughable. In recent years, DuPont has pleaded guilty to criminal price-fixing in its global elastomers venture, been caught by the FDA illegally misrepresenting its medical products, deceitfully covered up its toxic Teflon chemical pollution and studies, been adjudged covertly contaminating an entire West Virginia town with toxic chemcals for decades and then LYING ABOUT IT, waged a war of "dirty tricks" bankrolling secret front organisations to smear and defame a superior-performing competitor, Monsanto, undsoweiter.
The Chairman of the disreputable DuPont adds nothing to BAC, in the opinion of the undersigned investor...funfun..

Gone Nowhere in 8 Years

Driven by stunningly incompetent and unethical Management, DuPont has gone rigourously nowhere for more than 11 years. DD has plummeted from a peak in the mid-eighties in May 1998 to 31 and change, Friday, Sept.11, 2009 on much fewer outstanding shares. The total market value of the much shrunken DuPont has collapsed from $110 billion to $29 billion today. ...funfun..